You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study

Article info

Article menu
Immune cell therapies and immune cell engineering
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study

Authors

  • Carla S Walti Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Andrea N Loes Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAHoward Hughes Medical Institute, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Kiel Shuey Department of Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Elizabeth M Krantz Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Jim Boonyaratanakornkit Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADepartment of Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Jacob Keane-Candib Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Tillie Loeffelholz Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Caitlin R Wolf Department of Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Justin J Taylor Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Rebecca A Gardner Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, Washington, USADepartment of Pediatrics, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Damian J Green Department of Medicine, University of Washington, Seattle, Washington, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Andrew J Cowan Department of Medicine, University of Washington, Seattle, Washington, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • David G Maloney Department of Medicine, University of Washington, Seattle, Washington, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Cameron J Turtle Department of Medicine, University of Washington, Seattle, Washington, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Steven A Pergam Department of Medicine, University of Washington, Seattle, Washington, USAVaccine and Infectious Disease Division, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Helen Y Chu Department of Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Jesse D Bloom Howard Hughes Medical Institute, Seattle, Washington, USABasic Sciences Division, Computational Biology Program, and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Joshua A Hill Department of Medicine, University of Washington, Seattle, Washington, USAVaccine and Infectious Disease Division, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles

Citation

Walti CS, Loes AN, Shuey K, et al
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study
Journal for ImmunoTherapy of Cancer 2021;9:e003428. doi: 10.1136/jitc-2021-003428
Online issue publication 
June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.